Document ID: chunk:federal_register_of_legislation:F2024L01339:front:0:p2
Version: federal_register_of_legislation:F2024L01339
Segment Type: other
Provision Reference: 
Character Range: 2987–6305

members under the MRCA.
Note: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.
 1.                Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting retrocalcaneal heel bursitis or death from retrocalcaneal heel bursitis with the circumstances of a person's relevant service:
 1.           Running or jogging an average of at least 30 kilometres per week for the 4 weeks before clinical onset or clinical worsening;
 2.           undertaking weight bearing exercise involving repeated activity of the ankle joint on the affected side for:
         1.           a minimum intensity of 5 METS; and
         2.           for at least 4 hours per week; and
         3.           for at least the 4 weeks before clinical onset or clinical worsening;
Note 1: Examples of weight bearing exercise involving repeated activity of the ankle joint at a minimum intensity of 5 METS include marching, playing basketball, football, volleyball, and track and field (especially those activities that involve jumping).
Note 2: MET (metabolic equivalent) is a unit of measure of the level of physical capability of the cardiorespiratory system. For example, 1 MET = cardiorespiratory effort associated with a person sitting, 3-4 METs = cardiorespiratory effort associated with a person walking at average walking pace (5 km/h) or light gardening.
 1.           having one of the following systemic arthritic diseases at the time of  clinical onset or clinical worsening:
         1.           ankylosing spondylitis;
         2.           Behcet syndrome;
         3.           enteropathic spondyloarthropathy (arthritis associated with inflammatory bowel disease);
         4.           gout;
         5.           pseudogout (calcium pyrophosphate dihydrate) or crystal-induced arthropathy from the deposition of calcium hydroxyapatite or calcium oxalate;
         6.            psoriatic arthropathy;
         7.           reactive arthritis;
         8.           rheumatoid arthritis; or
         9.             undifferentiated spondyloarthropathy;
 2.           having chronic renal failure within the 10 years before clinical onset or clinical worsening as indicated by:
         1.           a glomerular filtration rate of less than 15 mL/min/1.73 m2 for a period of at least 3 months; or
         2.           undergoing chronic dialysis for renal failure;
 3.           having a bacterial infection of the affected retrocalcaneal bursa at the time of clinical onset or clinical worsening;
 4.           wearing footwear that causes excessive pressure on the posterior aspect of the heel of the affected foot, at the time of clinical onset or clinical worsening;
 5.           inability to obtain appropriate clinical management for retrocalcaneal heel bursitis before clinical worsening.
 1.            Relationship to service
         1.           The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
         2.           The clinical worsening aspects of factors set out in section 9 apply only to material contribution to, or aggravation of, retrocalcaneal heel bursitis where the person's retrocalcaneal